Literature DB >> 29380037

A novel heterozygous ITGB3 p.T720del inducing spontaneous activation of integrin αIIbβ3 in autosomal dominant macrothrombocytopenia with aggregation dysfunction.

Naohiro Miyashita1, Masahiro Onozawa2, Koji Hayasaka3, Takahiro Yamada4, Ohsuke Migita5, Kenichiro Hata5, Kohei Okada1, Hideki Goto1, Masao Nakagawa1, Daigo Hashimoto1, Kaoru Kahata1, Takeshi Kondo1, Shinji Kunishima6, Takanori Teshima1.   

Abstract

We identified a novel heterozygous ITGB3 p.T720del mutation in a pedigree with macrothrombocytopenia exhibiting aggregation dysfunction. Platelet aggregation induced by ADP and collagen was significantly reduced, while ristocetin aggregation was normal. Integrin αIIbβ3 was partially activated in a resting status, but platelet expression of αIIbβ3 was downregulated. Functional analysis using a cell line showed spontaneous phosphorylation of FAK in αIIb/β3 (p.T720del)-transfected 293T cells in suspension conditions. Abnormal cytoplasmic protrusions, membrane ruffling, and cytoplasmic localization of αIIbβ3 were observed in αIIb/β3 (p.T720del)-transfected CHO cells. Such morphological changes were reversed by treatment with an FAK inhibitor. These findings imply spontaneous, but partial, activation of αIIbβ3 followed by phosphorylation of FAK as the initial mechanism of abnormal thrombopoiesis. Internalization and decreased surface expression of αIIbβ3 would contribute to aggregation dysfunction. We reviewed the literature of congenital macrothrombocytopenia associated with heterozygous ITGA2B or ITGB3 mutations. Reported mutations were highly clustered at the membrane proximal region of αIIbβ3, which affected the critical interaction between αIIb R995 and β3 D723, resulting in a constitutionally active form of the αIIbβ3 complex. Macrothrombocytopenia caused by a heterozygous activating mutation of ITGA2B or ITGB3 at the membrane proximal region forms a distinct entity of rare congenital thrombocytopenia.

Entities:  

Keywords:  Congenital macrothrombocytopenia; FAK phosphorylation; ITGB3; Integrin αIIbβ3; Platelet

Mesh:

Substances:

Year:  2018        PMID: 29380037     DOI: 10.1007/s00277-017-3214-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  2 in total

1.  Anagrelide Modulates Proplatelet Formation Resulting in Decreased Number and Increased Size of Platelets.

Authors:  Naohiro Miyashita; Masahiro Onozawa; Shota Yokoyama; Daisuke Hidaka; Koji Hayasaka; Shinji Kunishima; Takanori Teshima
Journal:  Hemasphere       Date:  2019-08-07

2.  αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum.

Authors:  Sara Morais; Jorge Oliveira; Catarina Lau; Mónica Pereira; Marta Gonçalves; Catarina Monteiro; Ana Rita Gonçalves; Rui Matos; Marco Sampaio; Eugénia Cruz; Inês Freitas; Rosário Santos; Margarida Lima
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.